phosphoserine has been researched along with Cancer of Prostate in 14 studies
Phosphoserine: The phosphoric acid ester of serine.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The normal prostate development and prostate cancer progression are mediated by androgen receptor (AR)." | 1.37 | Regulation of androgen receptor and prostate cancer growth by cyclin-dependent kinase 5. ( Chen, MC; Chiang, MC; Hsu, FN; Huang, PH; Lee, GS; Lee, YT; Lin, E; Lin, H, 2011) |
| "Prostate cancer is the most frequently diagnosed male malignancy." | 1.37 | Regulation of androgen receptor and prostate cancer growth by cyclin-dependent kinase 5. ( Chen, MC; Chiang, MC; Hsu, FN; Huang, PH; Lee, GS; Lee, YT; Lin, E; Lin, H, 2011) |
| "These results demonstrate that, in prostate cancer cells, the efficacy of chemotherapy may be limited by its effects on the intracellular signaling pathways found within the cell." | 1.35 | Akt inactivates ERK causing decreased response to chemotherapeutic drugs in advanced CaP cells. ( Chappell, WH; Lee, JT; McCubrey, JA; Steelman, LS, 2008) |
| "Interestingly, 10 of 15 primary prostate cancers examined by Western blotting overexpressed acid ceramidase (AC), suggesting that ceramide deacylation might serve to negate elevated levels of ceramide, creating a more antiapoptotic phenotype." | 1.33 | Modulation of ceramide metabolism enhances viral protein apoptin's cytotoxicity in prostate cancer. ( Bielawska, A; Bielawski, J; Dong, JY; El-Zawahry, AM; Elojeimy, S; Guo, GW; Hannun, YA; Holman, DH; Keane, T; Liu, X; Norris, JS; Rubinchik, S; Tavassoli, M, 2006) |
| "Resveratrol causes apoptosis in DU 145 prostate cancer cells." | 1.31 | Resveratrol induced serine phosphorylation of p53 causes apoptosis in a mutant p53 prostate cancer cell line. ( Bennett, JA; Davis, FB; Davis, PJ; Lin, HY; Martino, LJ; Shih, A; Tang, HY, 2002) |
| "Whereas the early stage of prostate cancer is marked by excessive proliferation, in advanced stages of the disease, a decreased apoptotic death rate (increased cell survival) also contributes to net tumor growth." | 1.31 | Immunohistochemical demonstration of phospho-Akt in high Gleason grade prostate cancer. ( Bedolla, R; Brattain, M; Ghosh, PM; Kreisberg, JI; Malik, SN; Prihoda, T; Troyer, DA, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 6 (42.86) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Wen, S | 1 |
| Wei, Y | 1 |
| Zen, C | 1 |
| Xiong, W | 1 |
| Niu, Y | 1 |
| Zhao, Y | 1 |
| Cobb, LJ | 1 |
| Mehta, H | 1 |
| Cohen, P | 1 |
| Fu, YM | 1 |
| Lin, H | 2 |
| Liu, X | 2 |
| Fang, W | 1 |
| Meadows, GG | 1 |
| Hsu, FN | 1 |
| Chen, MC | 1 |
| Chiang, MC | 1 |
| Lin, E | 1 |
| Lee, YT | 1 |
| Huang, PH | 1 |
| Lee, GS | 1 |
| Jones, SE | 1 |
| Palmer, TM | 1 |
| Mao, L | 1 |
| Dauchy, RT | 1 |
| Blask, DE | 1 |
| Slakey, LM | 1 |
| Xiang, S | 1 |
| Yuan, L | 1 |
| Dauchy, EM | 1 |
| Shan, B | 1 |
| Brainard, GC | 1 |
| Hanifin, JP | 1 |
| Frasch, T | 1 |
| Duplessis, TT | 1 |
| Hill, SM | 1 |
| Liu, T | 1 |
| Li, Y | 1 |
| Gu, H | 1 |
| Zhu, G | 1 |
| Li, J | 1 |
| Cao, L | 1 |
| Li, F | 1 |
| Gupta, K | 1 |
| Thakur, VS | 1 |
| Bhaskaran, N | 1 |
| Nawab, A | 1 |
| Babcook, MA | 1 |
| Jackson, MW | 1 |
| Gupta, S | 1 |
| Lin, HY | 1 |
| Shih, A | 1 |
| Davis, FB | 1 |
| Tang, HY | 1 |
| Martino, LJ | 1 |
| Bennett, JA | 1 |
| Davis, PJ | 1 |
| Elojeimy, S | 1 |
| El-Zawahry, AM | 1 |
| Holman, DH | 1 |
| Bielawska, A | 1 |
| Bielawski, J | 1 |
| Rubinchik, S | 1 |
| Guo, GW | 1 |
| Dong, JY | 1 |
| Keane, T | 1 |
| Hannun, YA | 1 |
| Tavassoli, M | 1 |
| Norris, JS | 1 |
| Chen, S | 1 |
| Xu, Y | 1 |
| Yuan, X | 1 |
| Bubley, GJ | 1 |
| Balk, SP | 1 |
| Lee, JT | 1 |
| Steelman, LS | 1 |
| Chappell, WH | 1 |
| McCubrey, JA | 1 |
| Lapko, VN | 1 |
| Wells, TA | 1 |
| Song, PS | 1 |
| Malik, SN | 1 |
| Brattain, M | 1 |
| Ghosh, PM | 1 |
| Troyer, DA | 1 |
| Prihoda, T | 1 |
| Bedolla, R | 1 |
| Kreisberg, JI | 1 |
14 other studies available for phosphoserine and Cancer of Prostate
| Article | Year |
|---|---|
Long non-coding RNA NEAT1 promotes bone metastasis of prostate cancer through N6-methyladenosine.
Topics: Adenosine; Aged; Aged, 80 and over; Animals; Bone Neoplasms; Cell Line, Tumor; Core Binding Factor A | 2020 |
Enhancing the apoptotic potential of insulin-like growth factor-binding protein-3 in prostate cancer by modulation of CK2 phosphorylation.
Topics: Amino Acid Sequence; Animals; Apoptosis; Casein Kinase II; Cell Line, Tumor; Cell Nucleus; Cell Surv | 2009 |
Cell death of prostate cancer cells by specific amino acid restriction depends on alterations of glucose metabolism.
Topics: Amino Acids; Cell Death; Cell Line, Tumor; Fluorescent Antibody Technique; Glucose; Glycogen Synthas | 2010 |
Regulation of androgen receptor and prostate cancer growth by cyclin-dependent kinase 5.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase 5; Humans; Male; Mice; Models | 2011 |
Protein kinase A-mediated phosphorylation of RhoA on serine 188 triggers the rapid induction of a neuroendocrine-like phenotype in prostate cancer epithelial cells.
Topics: Carcinoma, Neuroendocrine; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Epithelial Cells; Human | 2012 |
Circadian gating of epithelial-to-mesenchymal transition in breast cancer cells via melatonin-regulation of GSK3β.
Topics: Animals; beta Catenin; Breast Neoplasms; Cell Line, Tumor; Circadian Rhythm; Enzyme Activation; Epit | 2012 |
p21-Activated kinase 6 (PAK6) inhibits prostate cancer growth via phosphorylation of androgen receptor and tumorigenic E3 ligase murine double minute-2 (Mdm2).
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Chlorocebus aethiops | 2013 |
Green tea polyphenols induce p53-dependent and p53-independent apoptosis in prostate cancer cells through two distinct mechanisms.
Topics: Acetylation; Apoptosis; bcl-2-Associated X Protein; Camptothecin; Cell Line, Tumor; Cell Survival; C | 2012 |
Resveratrol induced serine phosphorylation of p53 causes apoptosis in a mutant p53 prostate cancer cell line.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; DNA Mutational Analysis; Enzyme Activation; Gene Expre | 2002 |
Modulation of ceramide metabolism enhances viral protein apoptin's cytotoxicity in prostate cancer.
Topics: Adenoviridae; Animals; Apoptosis; Capsid Proteins; Caspases; Cell Line, Tumor; Ceramides; Enzyme Inh | 2006 |
Androgen receptor phosphorylation and stabilization in prostate cancer by cyclin-dependent kinase 1.
Topics: Androgens; CDC2 Protein Kinase; Cell Line, Tumor; Humans; Male; Phosphorylation; Phosphoserine; Pros | 2006 |
Akt inactivates ERK causing decreased response to chemotherapeutic drugs in advanced CaP cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Drug Screening Assays, Antitumor; Enzyme Activation; Enzyme | 2008 |
Protein kinase A-catalyzed phosphorylation and its effect on conformation in phytochrome A.
Topics: Acid Phosphatase; Adenoma; Adenosine Triphosphate; Amino Acid Sequence; Animals; Avena; Cattle; Circ | 1996 |
Immunohistochemical demonstration of phospho-Akt in high Gleason grade prostate cancer.
Topics: Humans; Immunohistochemistry; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Ki | 2002 |